# Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

> **NCT05686447** · — · RECRUITING · sponsor: **Zhujiang Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Monoclonal Gammopathies
- Multiple Myeloma
- M-protein

## Interventions

- **OTHER:** Observational studies, no intervention

## Key facts

- **NCT ID:** NCT05686447
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05686447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05686447, "Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05686447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*